V.P. Antipas

The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants

Christina Armpilia, Roger Dale, Ian Coles et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 80 citations · Full text

Medicine, Nuclear Medicine, Pharmacokinetics +12

A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide

Georgios Stamatakos, V.P. Antipas, N.K. Uzunoglu · IEEE Transactions on Biomedical Engineering · 2006 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of¹²⁵I and¹⁰³Pd

V.P. Antipas, Roger Dale, Ian Coles · Physics in Medicine and Biology · 2001 · 58 citations

Medicine, Nuclear Medicine, Oncology +15

A four-dimensional computer simulation model of the<i>in vivo</i>response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density

Georgios Stamatakos, V.P. Antipas, N.K. Uzunoglu et al. · British Journal of Radiology · 2006 · 57 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A spatio-temporal simulation model of the response of solid tumours to radiotherapy<i>in vivo</i>: parametric validation concerning oxygen enhancement ratio and cell cycle duration

V.P. Antipas, Georgios Stamatakos, N.K. Uzunoglu et al. · Physics in Medicine and Biology · 2004 · 33 citations · Full text

Medicine, Oncology, Radiation Oncology +17